Substituted morpholine and thiomorpholine derivatives for the treatment of bipolar disorders
申请人:H. LUNDBECK A/S
公开号:EP2138487A1
公开(公告)日:2009-12-30
The present invention relates to a compound of the general formula I or pharmaceutically acceptable salts thereof, for the treatment of a bipolar disorder.
本发明涉及一种通式 I 的化合物或其药学上可接受的盐类,用于治疗躁郁症。